State Medicaid Programs' Formulary Preference for Brand-Name Over Generic Drugs

This cross-sectional study explores the use of the brand-over-generic designation in the state Medicaid program formulary.

Authors

Institutions

Publication Details

Journal
JAMA Health Forum
Published
2026-11-06
DOI
https://doi.org/10.1001/jamahealthforum.2026.4002
Primary Topic
Pharmaceutical Economics and Policy
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

State Medicaid Programs' Formulary Preference for Brand-Name Over Generic Drugs

Sarah M. E. Gabriele, Aaron Seth Kesselheim, Benjamin N. Rome
1 links
JAMA Health Forum
Pharmaceutical Economics and Policy
article

State Medicaid Programs' Formulary Preference for Brand-Name Over Generic Drugs

Sarah M. E. Gabriele, Aaron Seth Kesselheim, Benjamin N. Rome
article en

Abstract

This cross-sectional study explores the use of the brand-over-generic designation in the state Medicaid program formulary.

JAMA Health ForumVol. 7(11)
Brigham and Women's Hospital (US), Harvard University (US)
Good health and well-being
Openalex Percentile: Top 11%
Pharmaceutical Economics and Policy
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
State Medicaid Programs' Formulary Preference for Brand-Name Over Generic Drugs — Sarah M. E. Gabriele, Aaron Seth Kesselheim, et al. · JAMA Health Forum (2026) | TGRS Research Map | TGRS